| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 18.4 | 17.2 |
| Gross profit | 10.8 | 10.1 |
| Profit before tax | -6.3 | -7.1 |
| Net income | -6.3 | -7.1 |
| EPS (diluted, $ a share) | $-0.25 | $-0.31 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +6.8% |
|---|---|
| Gross margin | 58.8% |
| Operating margin | -23.9% |
10-Q filed with the SEC, NASDAQ: XGN. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Exagen Inc.: key numbers
- Share price
- $3.77Close, Nov 16
- Market cap
- $96.2M
- Shares outstanding
- 25.51MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Medical LaboratoriesSIC 8071
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Exagen Inc.
All →Exagen Insider Jorey Chernett Sells $746K of Stock
Jorey Chernett sold 167,504 shares of Exagen Inc. at $4.08 to $4.65 a share (average $4.45) in 2 transactions, worth $746K in total between Nov 12, 2026 and Nov 13, 2026. Shares held after the trade: 2,529,436 (-2.2%).
- Value
- $746K
- Shares
- 167,504
- Average price
- $4.45
- Holding change
- -2.2%
- Trade date
- Nov 12, 2026 to Nov 13, 2026
Exagen Insider Jorey Chernett Buys $373K of Stock
Jorey Chernett bought 71,315 shares of Exagen Inc. at $5.23 a share, worth $373K in total on Nov 11, 2026. Shares held after the trade: 2,696,940 (+2.7%).
- Value
- $373K
- Shares
- 71,315
- Price
- $5.23
- Holding change
- +2.7%
- Trade date
- Nov 11, 2026
Exagen Insider Jorey Chernett Buys $91.2K of Stock
Jorey Chernett bought 15,585 shares of Exagen Inc. at $5.26 to $6.35 a share (average $5.85) in 2 transactions, worth $91.2K in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 2,625,625 (+0.3%).
- Value
- $91.2K
- Shares
- 15,585
- Average price
- $5.85
- Holding change
- +0.3%
- Trade date
- Nov 9, 2026 to Nov 10, 2026
Exagen Insider Jorey Chernett Sells $69.2K of Stock
Jorey Chernett sold 11,265 shares of Exagen Inc. at $6.14 a share, worth $69.2K in total on Nov 6, 2026. Shares held after the trade: 2,610,040 (-0.4%).
- Value
- $69.2K
- Shares
- 11,265
- Price
- $6.14
- Holding change
- -0.4%
- Trade date
- Nov 6, 2026
Exagen Financial Results
Exagen Inc. reported third quarter 2026 revenue of $18.4 million, a 7% increase year-over-year, driven by growth in test volume and average selling price. The company reduced its net loss to $6.3 million for the quarter and reiterated its full-year 2026 revenue guidance of $72 million to $75 million.
- Term
- Q3 2026
“Our third quarter extends what is fast becoming a record year for Exagen, and our ability to execute against our vision is increasingly evident in the results. The team grew the business again, with test volume and ASP both ahead of the same period last year.”
John Aballi, President and Chief Executive Officer of Exagen
Exagen Insider Jorey Chernett Buys $104K of Stock
Jorey Chernett bought 14,000 shares of Exagen Inc. at $7.46 a share, worth $104K in total on Oct 19, 2026. Shares held after the trade: 2,618,540 (+0.5%).
- Value
- $104K
- Shares
- 14,000
- Price
- $7.46
- Holding change
- +0.5%
- Trade date
- Oct 19, 2026